Icon

APTENSIO XR (nda205831)- (10MG,15MG,20MG,30MG,40MG,50MG,60MG)

METHYLPHENIDATE HYDROCHLORIDE RHODES PHARMS
10MG,15MG,20MG,30MG,40MG,50MG,60MG
Yes Yes
2022-Apr-12 Expired
None 2018-Apr-17
None No
APTENSIO XR is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older.
1 0 1
Total Other Developers None
Drugs with Suitability No
10MG ** ** - - 1
15MG ** ** - - 1
20MG ** ** - - 1
30MG ** ** - - 1
40MG ** ** - - 1
50MG ** ** - - 1
60MG ** ** - - 1
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.